AI summary by TwinMind
The Return of Silicon Valley’s Greatest Fraud
ColdFusion
12m 49s
Elizabeth Holmes Prison Interview & Return Plans
- Holmes (now 41) told People magazine she's writing patents from prison
- Plans to return to biotech after release
- Continues working on research/inventions from behind bars
- Committed to making affordable healthcare solutions available to everyone
- SEC banned her from serving as officer/director of any public company
- Can still help run private companies
Billy Evans & Hemanthus Company Formation
- Holmes' partner Billy Evans (30-year-old heir to California hotel fortune)
- They have 2 kids together, Holmes sees them twice weekly for 2 hours
- Evans actively raising money for biotech company Hemanthus
- Company describes itself as "future of diagnostics" with "radically new approach to health testing"
- Initial testing machine looks similar to Theranos Edison machine
- Uses artificial intelligence as key differentiator
Hemanthus Technology & Approach
- Uses Raman spectroscopy method (used in chemistry for ~100 years)
- Laser scans blood, saliva, or urine samples
- Analyzes samples on molecular level
- Deep learning model detects cancer and other issues in seconds
- Granted one patent so far
- Starting with pet healthcare (less regulation, multi-billion dollar market)
- Edgemon Partners calls it "recession proof industry"
- End goal: cheap wearable health scanner for humans
- Needs 3 years and $70 million to achieve human application
Company Structure & Leadership
- Evans previously worked at Luminina Technologies (autonomous vehicle sensors)
- No medical experience background
- ~20 advisors including veterinarians and diagnosticians
- ~10 employees currently
- Evans already raised millions according to NPR
Investor Response & Funding
- Many investors rejecting opportunity
- Michael Dell's investment firm promptly rejected
- Early Facebook investor/VC manager passed "for same reasons we passed twice on Theranos"
- Evans solicited $3.5 million from friends and family
- Seeking additional $15 million in San Francisco and Austin
- Only tracked investor: Matthew Parkhurst (runs tapas bar in Austin)
Scientific Validation & AI Breakthroughs
- AI pushing Raman spectroscopy field forward
- Johns Hopkins study: simple blood test for lung cancer detection
- Dr. Victor Velculescu: "could be done in doctor's office"
- Chinese study at Beijing Medical University:
- 99.7% accuracy in melanoma cell detection
- 97.9% accuracy for bacterial infections
- Similar US studies showing comparable results
- Challenge: translating working science to actual product
Company Response to Criticism
- May 11, 2025 X/Twitter statement from Hemanthus
- Acknowledged Evans is Holmes' partner
- "Skepticism is rational. We must make clear high bar"
- "Prefer to build first, talk later"
- "Science, when ready, will stand on its own merits"
- "This is not Theranos 2.0"
Holmes Current Status
- Serving 11 years in Texas prison
- 7 years remaining on sentence
- Recent appeal rejected
- Convicted in 2022 for defrauding Silicon Valley
- Original Theranos raised $945 million, valued at $9 billion
- Put patients at risk with false diagnoses
